Illumina Ventures is the CVC of Illumina, the dominant player in DNA sequencing, managing $560M+ in total AUM with Fund III targeting $200M (reduced from an initial $300M target). Across 51 investments, the portfolio includes foundational genomics companies: Twist Bioscience, CareDx, and Sherlock Biosciences, with 1 unicorn, 2 IPOs, and 12 acquisitions. Recent 2025 investments include Attovia Ther...
San Francisco, United States
Menlo Park, United States
Auckland, New Zealand
Boston, United States
New York, United States
Palo Alto, United States